ENDONOVO THERAPEUTICS, INC. (ENDV) Gross margin 2013–2022
ENDONOVO THERAPEUTICS, INC. (ENDV) gross margin by fiscal year — reported gross profit divided by reported revenue.
92.6%FY2022 · since FY2013: 38.9% → 92.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 92.6% | +13.1 pp |
| FY2021 | 79.5% | +18.9 pp |
| FY2020 | 60.6% | -9.3 pp |
| FY2019 | 69.9% | -14.6 pp |
| FY2018 | 84.5% | — |
| FY2015 | 49.3% | +13.3 pp |
| FY2014 | 36.0% | -2.9 pp |
| FY2013 | 38.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice